Harvey J. M. D. Berger is Chairman at ARIAD PHARMACEUTICALS INC (ARIA). They have made 1 open-market trade across 1 company since 2009, most recently 2015-12-31.
CIK 0000932052
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.9M since 2009, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARIA | 1,814,239 | $46.2M |
Shares reported on the most recent Form 4, priced at the 2016-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARIA | BUY | 2015-02-11 | 2015-02-13 | $6.84 | $171K | -13.2% | +0.2% | +0.2% |
| ARIA | BUY | 2015-01-22 | 2015-01-26 | $6.17 | $154K | -13.2% | +0.2% | +0.2% |
| ARIA | BUY | 2014-12-17 | 2014-12-19 | $6.35 | $159K | -13.2% | +0.2% | +0.2% |
| ARIA | BUY | 2014-11-19 | 2014-11-21 | $6.15 | $154K | -13.2% | +0.2% | +0.2% |
| ARIA | BUY | 2014-10-15 | 2014-10-17 | $5.25 | $131K | -13.2% | +0.2% | +0.2% |
| ARIA | BUY | 2014-09-02 | 2014-09-18 | $6.27 | $157K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2013-08-13 | 2013-08-15 | $18.33 | $2.2M | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2013-07-16 | 2013-07-18 | $19.84 | $4.0M | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2013-06-19 | 2013-06-21 | $18.00 | $202K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2013-05-14 | 2013-05-16 | $18.10 | $1.7M | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2013-04-17 | 2013-04-22 | $18.01 | $1.9M | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2013-03-12 | 2013-03-14 | $22.05 | $2.3M | -13.2% | +0.2% | +0.2% |
| ARIA | BUY | 2009-08-04 | 2009-08-06 | $1.75 | $3.0M | -13.2% | +0.2% | +0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.